MARKET INSIGHTS
Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit market size was valued at USD 13.4 million in 2024. The market is projected to grow from USD 14.4 million in 2025 to USD 21.9 million by 2032, exhibiting a CAGR of 7.5% during the forecast period.
Insulin-like Growth Factor 1 (IGF-1) ELISA Kits are immunoassay tools designed to quantitatively measure IGF-1 concentrations in biological samples. These kits utilize the enzyme-linked immunosorbent assay (ELISA) principle, combining the specificity of antibodies with the sensitivity of enzyme detection. IGF-1, a hormone structurally similar to insulin, plays critical roles in growth regulation, cellular proliferation, and metabolism, making its measurement vital for both clinical diagnostics and research applications.
Market growth is primarily driven by increasing prevalence of growth-related disorders, rising demand for hormone testing in clinical settings, and expanding research in endocrinology and oncology. The human IGF-1 ELISA kits segment dominates the market, holding over 60% share in 2024, due to extensive clinical applications in diagnosing growth hormone deficiency and acromegaly. Key manufacturers are focusing on product innovations, with recent developments including high-sensitivity kits for low-concentration samples and multiplex assay platforms that simultaneously measure IGF-1 with related biomarkers.
MARKET DYNAMICS
MARKET DRIVERS
Rising Prevalence of Growth Hormone Disorders to Accelerate Market Growth
The global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit market is experiencing significant growth due to increasing diagnosis and monitoring of growth hormone-related disorders. With over 10,000 cases of pediatric growth hormone deficiency diagnosed annually worldwide, the demand for accurate IGF-1 measurement tools has surged. IGF-1 serves as a key marker for growth hormone activity, making these ELISA kits indispensable in clinical diagnostics. The growing awareness about early diagnosis and intervention for growth disorders, particularly in pediatric populations, is driving widespread adoption of these testing solutions across healthcare facilities.
Technological Advancements in Diagnostics to Fuel Market Expansion
Recent innovations in ELISA technology have significantly enhanced the sensitivity and specificity of IGF-1 detection kits. Modern kits now offer improved detection limits down to 0.1 ng/ml, enabling more accurate diagnosis of growth hormone disorders. The development of automated ELISA systems has reduced testing time from hours to minutes while maintaining high precision. These technological improvements are particularly valuable in high-throughput clinical laboratories processing hundreds of samples daily, driving replacement demand and upgrades of older testing systems.
Furthermore, the integration of digital data management systems with ELISA platforms allows for seamless result tracking and longitudinal patient monitoring, creating additional value for healthcare providers. The convergence of traditional ELISA methods with emerging digital health technologies presents significant opportunities for market players to differentiate their offerings.
MARKET RESTRAINTS
High Cost of Advanced ELISA Kits to Limit Market Penetration
While the IGF-1 ELISA Kit market shows strong growth potential, the high cost of advanced testing systems presents a significant barrier to adoption. Premium ELISA kits with enhanced sensitivity can cost 2-3 times more than basic kits, making them prohibitive for many healthcare facilities in price-sensitive markets. This cost factor is particularly acute in developing regions where healthcare budgets are constrained, limiting market expansion despite growing clinical need.
The substantial investment required for automated ELISA systems, ranging from $50,000 to $200,000 per unit, further restricts adoption among smaller laboratories and clinics. While these systems offer superior efficiency and accuracy, the capital expenditure required often exceeds the financial capacity of many healthcare providers, particularly in emerging economies.
MARKET OPPORTUNITIES
Emerging Markets to Offer Significant Growth Potential
Developing regions represent a major growth opportunity for the IGF-1 ELISA Kit market, with expanding healthcare infrastructure and increasing healthcare expenditure. Countries in Asia and Latin America are particularly promising, with projections indicating a 9-12% annual growth in diagnostic testing markets through 2030. The rising middle class in these regions is driving demand for advanced diagnostic services, including growth hormone testing.
Local manufacturers are increasingly developing cost-effective ELISA solutions tailored to these markets, addressing price sensitivity while maintaining acceptable accuracy levels. These region-specific product strategies, combined with government initiatives to improve child healthcare, create favorable conditions for market expansion in emerging economies.
MARKET CHALLENGES
Regulatory Hurdles to Impact Market Dynamics
The IGF-1 ELISA Kit market faces significant regulatory challenges that impact product development and market entry timelines. Obtaining regulatory approvals for diagnostic kits can take 12-18 months in major markets, delaying product launches and increasing development costs. The stringent validation requirements for ELISA kits, particularly those used for clinical diagnosis, create additional compliance burdens for manufacturers.
Differing regulatory standards across regions further complicate market expansion strategies, requiring manufacturers to navigate multiple approval processes. These regulatory complexities particularly disadvantage smaller manufacturers with limited resources, potentially consolidating market share among larger, established players.
Segment Analysis:
By Type
Human IGF-1 ELISA Kits Dominate the Market Due to Widespread Clinical and Research Applications
The market is segmented based on type into:
-
Human
-
Mouse
-
Rat
-
Bovine
-
Others
By Application
Research Institutes Lead the Market Due to Extensive Use in Scientific Studies
The market is segmented based on application into:
-
Hospitals
-
Research Institutes
-
Pharmaceutical Companies
-
Diagnostic Centers
-
Others
By End User
Academic and Government Research Institutes Hold Significant Market Share
The market is segmented based on end user into:
-
Academic Research Institutions
-
Pharmaceutical and Biotechnology Companies
-
Hospitals and Diagnostic Centers
-
Contract Research Organizations
-
Others
By Sensitivity
High Sensitivity Kits are Gaining Traction for Critical Research Applications
The market is segmented based on sensitivity into:
COMPETITIVE LANDSCAPE
Key Industry Players
Strategic Product Innovation and Regional Expansion Define Market Competition
The global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit market exhibits a fragmented but dynamic competitive landscape, with established life science giants competing alongside specialized biotechnology firms. While many players operate in this space, a select few dominate revenue share through technological superiority and diversified portfolios. Thermo Fisher Scientific leads the market with an estimated 18% revenue share in 2024, leveraging its comprehensive catalog of ELISA kits and direct sales channels across 50+ countries.
Chinese manufacturers like Wuhan Fine Biotech and Shanghai Korain Biotech have gained significant ground in price-sensitive markets, offering cost-effective alternatives without compromising detection accuracy. Their growth mirrors Asia's expanding biotech sector, which now accounts for 32% of global IGF-1 kit production. Meanwhile, Western firms emphasize premium products - Bio-Techne's high-sensitivity kits command 40% price premiums in research applications, reflecting their value in precision diagnostics.
The competitive intensity has increased as companies target different market segments. While some focus on high-throughput hospital diagnostics, others cater to academic research with customizable kits. RayBiotech recently launched multiplex ELISA panels combining IGF-1 with related biomarkers, addressing the growing demand for comprehensive metabolic profiling. This trend toward integrated solutions is reshaping competitive dynamics more than price wars in the space.
Strategic acquisitions continue to redraw market boundaries. Abbexa's 2023 purchase of ZodelBiotec expanded its ELISA kit range and distribution network across Eastern Europe. Such M&A activity suggests the market may consolidate further as mid-sized players seek scale against dominant competitors. However, innovation remains the ultimate differentiator - companies investing in automation compatibility and AI-assisted data analysis are positioning for future growth.
List of Key IGF-1 ELISA Kit Providers Profiled
INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) ELISA KIT MARKET TRENDS
Increasing Prevalence of Metabolic Disorders Driving IGF-1 ELISA Kit Demand
The global healthcare landscape is witnessing a dramatic rise in metabolic disorders such as diabetes, obesity, and growth hormone deficiencies, creating substantial demand for IGF-1 diagnostic solutions. With over 537 million adults worldwide affected by diabetes alone, the need for accurate biomarkers like IGF-1 for metabolic assessment continues to grow. ELISA kits provide critical quantitative analysis of IGF-1 levels, enabling clinicians to monitor disease progression and therapeutic efficacy. Recent technological advancements have improved kit sensitivity to detect IGF-1 concentrations as low as 0.1 ng/ml, significantly enhancing diagnostic precision.
Other Trends
Expansion of Anti-Aging Research
IGF-1's role in cellular regeneration and tissue repair has positioned it as a biomarker of interest in aging research. The global anti-aging market, projected to exceed $119 billion by 2030, is fueling demand for reliable IGF-1 testing solutions. Research institutes are increasingly utilizing high-sensitivity ELISA kits to study IGF-1's correlation with longevity biomarkers, with recent studies demonstrating its predictive value for age-related decline. This application segment currently accounts for approximately 18% of total IGF-1 ELISA kit utilization.
Technological Advancements in Assay Development
Manufacturers are integrating innovative detection technologies to improve IGF-1 ELISA performance. The introduction of automated microplate readers with multiplexing capabilities has reduced processing time by 40% while maintaining 99% accuracy. New chemiluminescent detection methods now offer wider dynamic ranges (>3 log units) compared to traditional colorimetric assays. Additionally, the development of room-temperature stable reagents has extended shelf-life by 30%, addressing previous cold-chain logistics challenges. These innovations are particularly crucial for emerging markets where laboratory infrastructure remains limited.
Expanding Applications in Sports Medicine
The sports medicine sector presents a growing vertical for IGF-1 ELISA kits, driven by both professional athletic programs and recreational fitness communities. IGF-1 monitoring helps trainers optimize muscle recovery protocols while supporting doping control efforts. Regulatory agencies have standardized cutoff values for IGF-1 in performance enhancement screenings, creating consistent demand for validated testing solutions. The segment is expected to grow at 8.2% CAGR through 2030, faster than the overall market average.
Regional Analysis: Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market
North America
The North American IGF-1 ELISA Kit market is characterized by advanced healthcare infrastructure, significant R&D investments, and strong regulatory frameworks led by agencies like the FDA. The region holds approximately 35% of the global market share, driven by rising demand for early disease diagnosis and personalized medicine. Research institutions and pharmaceutical companies in the U.S. and Canada heavily utilize IGF-1 detection kits for metabolic disorder studies, cancer research, and growth hormone deficiency assessments. While pricing pressures exist due to reimbursement policies, technological advancements—such as high-sensitivity ELISA kits from manufacturers like Thermo Fisher Scientific—maintain steady growth. Furthermore, increasing collaborations between academic institutions and biotech firms fuel innovation in this space.
Europe
Europe follows closely behind North America, with Germany, France, and the U.K. leading adoption due to well-established biotech sectors and government-funded research programs. The European IGF-1 ELISA Kit market benefits from standardized diagnostic protocols under EU IVDR regulations, ensuring product reliability. Growth is propelled by increasing diabetes prevalence and aging populations requiring growth hormone monitoring—Germany alone accounts for over 25% of regional revenue. However, stringent approval processes and competition from alternative detection methods, such as mass spectrometry, pose challenges. Recent trends include a shift toward automated ELISA systems to improve lab efficiency.
Asia-Pacific
As the fastest-growing region, Asia-Pacific is projected to surpass European market valuation by 2028, led by China, Japan, and India. Expanding healthcare access, rising disposable incomes, and government initiatives to boost biotech innovation drive demand—yet cost sensitivity remains a key factor. Local manufacturers like Shanghai Korain Biotech dominate the mid-tier segment, while multinational players target premium-end research labs. India’s market is emerging, fueled by increasing clinical trials and metabolic disease research. Despite fragmented regulatory frameworks, CAGR exceeds 9% due to large patient pools and growing awareness of IGF-1’s diagnostic role.
South America
South America’s IGF-1 ELISA Kit market faces constraints like limited healthcare budgets and import dependency but shows potential in Brazil and Argentina. Academic research centers and large-scale epidemiological studies contribute to steady demand. Brazil leads regional sales, accounting for 40% of volume, though inconsistent supply chains and economic instability hinder scalability. Nonetheless, partnerships between public health agencies and global distributors aim to improve accessibility. The market remains concentrated in urban hubs, with niche opportunities in sports medicine and pediatric growth disorder diagnostics.
Middle East & Africa
This region represents an untapped market, with growth concentrated in GCC countries (e.g., Saudi Arabia, UAE) due to improving healthcare infrastructure. Diagnostic labs and research institutes increasingly adopt ELISA kits for chronic disease management, though reliance on imports inflates costs. Africa’s market is nascent, constrained by low awareness and funding gaps—yet initiatives like the African Continental Free Trade Area (AfCFTA) could enhance distribution networks. Local production is nearly absent, creating opportunities for partnerships with global suppliers to address unmet needs in endocrine disorder diagnostics.
Report Scope
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Key Coverage Areas:
-
✅ Market Overview
-
✅ Segmentation Analysis
-
By product type or category
-
By application or usage area
-
By end-user industry
-
By distribution channel (if applicable)
-
✅ Regional Insights
-
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
-
Country-level data for key markets
-
✅ Competitive Landscape
-
Company profiles and market share analysis
-
Key strategies: M&A, partnerships, expansions
-
Product portfolio and pricing strategies
-
✅ Technology & Innovation
-
Emerging technologies and R&D trends
-
Automation, digitalization, sustainability initiatives
-
Impact of AI, IoT, or other disruptors (where applicable)
-
✅ Market Dynamics
-
Key drivers supporting market growth
-
Restraints and potential risk factors
-
Supply chain trends and challenges
-
✅ Opportunities & Recommendations
-
✅ Stakeholder Insights
-
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
FREQUENTLY ASKED QUESTIONS:
What is the current market size of Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market?
-> Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit market was valued at USD 13.4 million in 2024 and is projected to reach USD 21.9 million by 2032, growing at a CAGR of 7.5% during the forecast period.
Which key companies operate in Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market?
-> Key players include Thermo Fisher Scientific, Abcam, Bio-Techne, Elabscience Biotechnology, MyBiosource, RayBiotech, and Creative Diagnostics, among others.
What are the key growth drivers?
-> Key growth drivers include rising prevalence of growth disorders, increasing research activities in oncology and endocrinology, and growing demand for precise diagnostic tools.
Which region dominates the market?
-> North America currently holds the largest market share, while Asia-Pacific is expected to witness the fastest growth during the forecast period.
What are the emerging trends?
-> Emerging trends include development of high-sensitivity ELISA kits, automation in diagnostic processes, and increasing adoption in academic research.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Overall Market Size
2.1 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size: 2024 VS 2032
2.2 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales: 2020-2032
3 Company Landscape
3.1 Top Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Players in Global Market
3.2 Top Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies Ranked by Revenue
3.3 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue by Companies
3.4 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales by Companies
3.5 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Type
3.8 Tier 1, Tier 2, and Tier 3 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Players in Global Market
3.8.1 List of Global Tier 1 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size Markets, 2024 & 2032
4.1.2 Human
4.1.3 Mouse
4.1.4 Rat
4.1.5 Bovine
4.1.6 Others
4.2 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue & Forecasts
4.2.1 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2025
4.2.2 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2026-2032
4.2.3 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales & Forecasts
4.3.1 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2025
4.3.2 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2026-2032
4.3.3 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
4.4 Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Research Institute
5.1.4 Others
5.2 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue & Forecasts
5.2.1 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2025
5.2.2 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2026-2032
5.2.3 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales & Forecasts
5.3.1 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2025
5.3.2 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2026-2032
5.3.3 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
5.4 Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2024 & 2032
6.2 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue & Forecasts
6.2.1 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2025
6.2.2 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2026-2032
6.2.3 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
6.3 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales & Forecasts
6.3.1 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2025
6.3.2 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2026-2032
6.3.3 By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2032
6.4.2 By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2032
6.4.3 United States Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.4.4 Canada Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.4.5 Mexico Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2032
6.5.2 By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2032
6.5.3 Germany Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.4 France Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.5 U.K. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.6 Italy Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.7 Russia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.8 Nordic Countries Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.5.9 Benelux Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2032
6.6.2 By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2032
6.6.3 China Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.6.4 Japan Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.6.5 South Korea Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.6.6 Southeast Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.6.7 India Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2032
6.7.2 By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2032
6.7.3 Brazil Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.7.4 Argentina Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, 2020-2032
6.8.3 Turkey Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.8.4 Israel Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.8.5 Saudi Arabia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
6.8.6 UAE Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Elabscience Biotechnology Inc.
7.1.1 Elabscience Biotechnology Inc. Company Summary
7.1.2 Elabscience Biotechnology Inc. Business Overview
7.1.3 Elabscience Biotechnology Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.1.4 Elabscience Biotechnology Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.1.5 Elabscience Biotechnology Inc. Key News & Latest Developments
7.2 Abcam
7.2.1 Abcam Company Summary
7.2.2 Abcam Business Overview
7.2.3 Abcam Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.2.4 Abcam Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.2.5 Abcam Key News & Latest Developments
7.3 Shanghai Korain Biotech Co., Ltd.
7.3.1 Shanghai Korain Biotech Co., Ltd. Company Summary
7.3.2 Shanghai Korain Biotech Co., Ltd. Business Overview
7.3.3 Shanghai Korain Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.3.4 Shanghai Korain Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.3.5 Shanghai Korain Biotech Co., Ltd. Key News & Latest Developments
7.4 Thermo Fisher Scientific (China) Co., Ltd.
7.4.1 Thermo Fisher Scientific (China) Co., Ltd. Company Summary
7.4.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
7.4.3 Thermo Fisher Scientific (China) Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.4.4 Thermo Fisher Scientific (China) Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.4.5 Thermo Fisher Scientific (China) Co., Ltd. Key News & Latest Developments
7.5 MyBiosource, Inc.
7.5.1 MyBiosource, Inc. Company Summary
7.5.2 MyBiosource, Inc. Business Overview
7.5.3 MyBiosource, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.5.4 MyBiosource, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.5.5 MyBiosource, Inc. Key News & Latest Developments
7.6 Bio-Techne
7.6.1 Bio-Techne Company Summary
7.6.2 Bio-Techne Business Overview
7.6.3 Bio-Techne Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.6.4 Bio-Techne Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.6.5 Bio-Techne Key News & Latest Developments
7.7 Wuhan Fine Biotech Co., Ltd.
7.7.1 Wuhan Fine Biotech Co., Ltd. Company Summary
7.7.2 Wuhan Fine Biotech Co., Ltd. Business Overview
7.7.3 Wuhan Fine Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.7.4 Wuhan Fine Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.7.5 Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
7.8 RayBiotech, Inc.
7.8.1 RayBiotech, Inc. Company Summary
7.8.2 RayBiotech, Inc. Business Overview
7.8.3 RayBiotech, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.8.4 RayBiotech, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.8.5 RayBiotech, Inc. Key News & Latest Developments
7.9 Creative Diagnostics
7.9.1 Creative Diagnostics Company Summary
7.9.2 Creative Diagnostics Business Overview
7.9.3 Creative Diagnostics Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.9.4 Creative Diagnostics Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.9.5 Creative Diagnostics Key News & Latest Developments
7.10 CLOUD-CLONE CORP.
7.10.1 CLOUD-CLONE CORP. Company Summary
7.10.2 CLOUD-CLONE CORP. Business Overview
7.10.3 CLOUD-CLONE CORP. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.10.4 CLOUD-CLONE CORP. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.10.5 CLOUD-CLONE CORP. Key News & Latest Developments
7.11 Enzo Life Sciences, Inc.
7.11.1 Enzo Life Sciences, Inc. Company Summary
7.11.2 Enzo Life Sciences, Inc. Business Overview
7.11.3 Enzo Life Sciences, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.11.4 Enzo Life Sciences, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.11.5 Enzo Life Sciences, Inc. Key News & Latest Developments
7.12 CUSABIO
7.12.1 CUSABIO Company Summary
7.12.2 CUSABIO Business Overview
7.12.3 CUSABIO Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.12.4 CUSABIO Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.12.5 CUSABIO Key News & Latest Developments
7.13 Abbexa
7.13.1 Abbexa Company Summary
7.13.2 Abbexa Business Overview
7.13.3 Abbexa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.13.4 Abbexa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.13.5 Abbexa Key News & Latest Developments
7.14 BioVendor R&D
7.14.1 BioVendor R&D Company Summary
7.14.2 BioVendor R&D Business Overview
7.14.3 BioVendor R&D Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.14.4 BioVendor R&D Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.14.5 BioVendor R&D Key News & Latest Developments
7.15 Assay Genie
7.15.1 Assay Genie Company Summary
7.15.2 Assay Genie Business Overview
7.15.3 Assay Genie Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.15.4 Assay Genie Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.15.5 Assay Genie Key News & Latest Developments
7.16 Boster Biological Technology
7.16.1 Boster Biological Technology Company Summary
7.16.2 Boster Biological Technology Business Overview
7.16.3 Boster Biological Technology Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.16.4 Boster Biological Technology Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.16.5 Boster Biological Technology Key News & Latest Developments
7.17 Biomatik
7.17.1 Biomatik Company Summary
7.17.2 Biomatik Business Overview
7.17.3 Biomatik Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.17.4 Biomatik Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.17.5 Biomatik Key News & Latest Developments
7.18 Innovative Research
7.18.1 Innovative Research Company Summary
7.18.2 Innovative Research Business Overview
7.18.3 Innovative Research Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.18.4 Innovative Research Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.18.5 Innovative Research Key News & Latest Developments
7.19 OriGene Technologies, Inc.
7.19.1 OriGene Technologies, Inc. Company Summary
7.19.2 OriGene Technologies, Inc. Business Overview
7.19.3 OriGene Technologies, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.19.4 OriGene Technologies, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.19.5 OriGene Technologies, Inc. Key News & Latest Developments
7.20 ZodelBiotec Ltd.
7.20.1 ZodelBiotec Ltd. Company Summary
7.20.2 ZodelBiotec Ltd. Business Overview
7.20.3 ZodelBiotec Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.20.4 ZodelBiotec Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.20.5 ZodelBiotec Ltd. Key News & Latest Developments
7.21 Geno Technology, Inc.
7.21.1 Geno Technology, Inc. Company Summary
7.21.2 Geno Technology, Inc. Business Overview
7.21.3 Geno Technology, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.21.4 Geno Technology, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.21.5 Geno Technology, Inc. Key News & Latest Developments
7.22 Crystal Chem
7.22.1 Crystal Chem Company Summary
7.22.2 Crystal Chem Business Overview
7.22.3 Crystal Chem Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Major Product Offerings
7.22.4 Crystal Chem Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales and Revenue in Global (2020-2025)
7.22.5 Crystal Chem Key News & Latest Developments
8 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production Capacity, Analysis
8.1 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production Capacity, 2020-2032
8.2 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Supply Chain Analysis
10.1 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Industry Value Chain
10.2 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Upstream Market
10.3 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Insulin-like Growth Factor 1 (IGF-1) ELISA Kit in Global Market
Table 2. Top Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Share by Companies, 2020-2025
Table 5. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales by Companies, (K Units), 2020-2025
Table 6. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Type
Table 9. List of Global Tier 1 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), 2026-2032
Table 16. Segment by Application – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 21. By Region – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 25. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 26. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 29. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 30. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 33. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 34. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 37. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 38. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 41. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, (K Units), 2026-2032
Table 46. Elabscience Biotechnology Inc. Company Summary
Table 47. Elabscience Biotechnology Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 48. Elabscience Biotechnology Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Elabscience Biotechnology Inc. Key News & Latest Developments
Table 50. Abcam Company Summary
Table 51. Abcam Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 52. Abcam Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Abcam Key News & Latest Developments
Table 54. Shanghai Korain Biotech Co., Ltd. Company Summary
Table 55. Shanghai Korain Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 56. Shanghai Korain Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Shanghai Korain Biotech Co., Ltd. Key News & Latest Developments
Table 58. Thermo Fisher Scientific (China) Co., Ltd. Company Summary
Table 59. Thermo Fisher Scientific (China) Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 60. Thermo Fisher Scientific (China) Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Thermo Fisher Scientific (China) Co., Ltd. Key News & Latest Developments
Table 62. MyBiosource, Inc. Company Summary
Table 63. MyBiosource, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 64. MyBiosource, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. MyBiosource, Inc. Key News & Latest Developments
Table 66. Bio-Techne Company Summary
Table 67. Bio-Techne Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 68. Bio-Techne Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Bio-Techne Key News & Latest Developments
Table 70. Wuhan Fine Biotech Co., Ltd. Company Summary
Table 71. Wuhan Fine Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 72. Wuhan Fine Biotech Co., Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
Table 74. RayBiotech, Inc. Company Summary
Table 75. RayBiotech, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 76. RayBiotech, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. RayBiotech, Inc. Key News & Latest Developments
Table 78. Creative Diagnostics Company Summary
Table 79. Creative Diagnostics Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 80. Creative Diagnostics Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Creative Diagnostics Key News & Latest Developments
Table 82. CLOUD-CLONE CORP. Company Summary
Table 83. CLOUD-CLONE CORP. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 84. CLOUD-CLONE CORP. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. CLOUD-CLONE CORP. Key News & Latest Developments
Table 86. Enzo Life Sciences, Inc. Company Summary
Table 87. Enzo Life Sciences, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 88. Enzo Life Sciences, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Enzo Life Sciences, Inc. Key News & Latest Developments
Table 90. CUSABIO Company Summary
Table 91. CUSABIO Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 92. CUSABIO Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. CUSABIO Key News & Latest Developments
Table 94. Abbexa Company Summary
Table 95. Abbexa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 96. Abbexa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Abbexa Key News & Latest Developments
Table 98. BioVendor R&D Company Summary
Table 99. BioVendor R&D Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 100. BioVendor R&D Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. BioVendor R&D Key News & Latest Developments
Table 102. Assay Genie Company Summary
Table 103. Assay Genie Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 104. Assay Genie Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Assay Genie Key News & Latest Developments
Table 106. Boster Biological Technology Company Summary
Table 107. Boster Biological Technology Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 108. Boster Biological Technology Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Boster Biological Technology Key News & Latest Developments
Table 110. Biomatik Company Summary
Table 111. Biomatik Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 112. Biomatik Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Biomatik Key News & Latest Developments
Table 114. Innovative Research Company Summary
Table 115. Innovative Research Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 116. Innovative Research Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 117. Innovative Research Key News & Latest Developments
Table 118. OriGene Technologies, Inc. Company Summary
Table 119. OriGene Technologies, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 120. OriGene Technologies, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 121. OriGene Technologies, Inc. Key News & Latest Developments
Table 122. ZodelBiotec Ltd. Company Summary
Table 123. ZodelBiotec Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 124. ZodelBiotec Ltd. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 125. ZodelBiotec Ltd. Key News & Latest Developments
Table 126. Geno Technology, Inc. Company Summary
Table 127. Geno Technology, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 128. Geno Technology, Inc. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 129. Geno Technology, Inc. Key News & Latest Developments
Table 130. Crystal Chem Company Summary
Table 131. Crystal Chem Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Offerings
Table 132. Crystal Chem Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 133. Crystal Chem Key News & Latest Developments
Table 134. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 135. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Capacity Market Share of Key Manufacturers, 2023-2025
Table 136. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production by Region, 2020-2025 (K Units)
Table 137. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production by Region, 2026-2032 (K Units)
Table 138. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Opportunities & Trends in Global Market
Table 139. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Drivers in Global Market
Table 140. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Restraints in Global Market
Table 141. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Raw Materials
Table 142. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Raw Materials Suppliers in Global Market
Table 143. Typical Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Downstream
Table 144. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Downstream Clients in Global Market
Table 145. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Product Picture
Figure 2. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Segment by Type in 2024
Figure 3. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Segment by Application in 2024
Figure 4. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue: 2020-2032 (US$, Mn)
Figure 8. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue in 2024
Figure 10. Segment by Type – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price (US$/Unit), 2020-2032
Figure 14. Segment by Application – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Price (US$/Unit), 2020-2032
Figure 18. By Region – Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 21. By Region - Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 22. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 23. By Country - North America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 24. United States Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 29. Germany Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 30. France Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales Market Share, 2020-2032
Figure 38. China Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 42. India Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue Market Share, 2020-2032
Figure 44. By Country - South America Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, Market Share, 2020-2032
Figure 45. Brazil Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Sales, Market Share, 2020-2032
Figure 49. Turkey Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 53. Global Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Insulin-like Growth Factor 1 (IGF-1) ELISA Kit by Region, 2024 VS 2032
Figure 55. Insulin-like Growth Factor 1 (IGF-1) ELISA Kit Industry Value Chain
Figure 56. Marketing Channels
